US 12150959
Chimeric antigen receptors with BCMA specificity and uses thereof
granted A61KA61K2239/13A61K2239/31
Quick answer
US patent 12150959 (Chimeric antigen receptors with BCMA specificity and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K2239/13, A61K2239/31, A61K2239/38, A61K2239/48